Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Validation of a routine two-sample iohexol plasma clearance assessment of GFR and an evaluation of common endogenous markers in a rat model of CKD.

Turner ME, Laverty KJ, Jeronimo PS, Kaufmann M, Jones G, White CA, Holden RM, Adams MA.

Physiol Rep. 2017 May;5(9). pii: e13205. doi: 10.14814/phy2.13205.

2.

Inhibiting the progression of arterial calcification with vitamin K in HemoDialysis patients (iPACK-HD) trial: rationale and study design for a randomized trial of vitamin K in patients with end stage kidney disease.

Holden RM, Booth SL, Day AG, Clase CM, Zimmerman D, Moist L, Shea MK, McCabe KM, Jamal SA, Tobe S, Weinstein J, Madhumathi R, Adams MA, Heyland DK.

Can J Kidney Health Dis. 2015 May 1;2:17. doi: 10.1186/s40697-015-0053-x. eCollection 2015.

3.

Assessment of potential biomarkers of subclinical vitamin K deficiency in patients with end-stage kidney disease.

Elliott MJ, Booth SL, Hopman WM, Holden RM.

Can J Kidney Health Dis. 2014 Jun 24;1:13. doi: 10.1186/2054-3581-1-13. eCollection 2014.

4.

Vitamin K status in chronic kidney disease.

McCabe KM, Adams MA, Holden RM.

Nutrients. 2013 Nov 7;5(11):4390-8. doi: 10.3390/nu5114390. Review.

5.

Water-soluble vitamins in people with low glomerular filtration rate or on dialysis: a review.

Clase CM, Ki V, Holden RM.

Semin Dial. 2013 Sep-Oct;26(5):546-67. doi: 10.1111/sdi.12099. Epub 2013 Jul 17. Review.

6.

Phosphate: an old bone molecule but new cardiovascular risk factor.

Shobeiri N, Adams MA, Holden RM.

Br J Clin Pharmacol. 2014 Jan;77(1):39-54. doi: 10.1111/bcp.12117. Review.

7.

Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3-5 chronic kidney disease.

Kerr JD, Holden RM, Morton AR, Nolan RL, Hopman WM, Pruss CM, Garland JS.

BMC Nephrol. 2013 Jan 26;14:26. doi: 10.1186/1471-2369-14-26.

8.

Vitamin K status and vascular calcification: evidence from observational and clinical studies.

Shea MK, Holden RM.

Adv Nutr. 2012 Mar 1;3(2):158-65. doi: 10.3945/an.111.001644. Review.

9.

Vitamins K and D status in stages 3-5 chronic kidney disease.

Holden RM, Morton AR, Garland JS, Pavlov A, Day AG, Booth SL.

Clin J Am Soc Nephrol. 2010 Apr;5(4):590-7. doi: 10.2215/CJN.06420909. Epub 2010 Feb 18.

10.

Antiplatelet medications in hemodialysis patients: a systematic review of bleeding rates.

Hiremath S, Holden RM, Fergusson D, Zimmerman DL.

Clin J Am Soc Nephrol. 2009 Aug;4(8):1347-55. doi: 10.2215/CJN.00810209. Epub 2009 Jul 2. Review.

11.

Major bleeding in hemodialysis patients.

Holden RM, Harman GJ, Wang M, Holland D, Day AG.

Clin J Am Soc Nephrol. 2008 Jan;3(1):105-10. Epub 2007 Nov 14.

Supplemental Content

Loading ...
Support Center